Published • loading... • Updated
Boston Scientific’s Coronary IVL Catheter Hits Primary Endpoints in Trial
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial
Boston Scientific plans to use the IDE trials results to support a regulatory filing of its Seismiq 4CE Coronary catheter with the FDA.The post Boston Scientific’s coronary IVL catheter hits primary endpoints in trial appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
